Artelo Biosciences, Inc.
ARTL
$5.98
-$0.21-3.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 103.19% | 1,277.08% | -74.34% | -64.59% | -63.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.59% | -30.19% | -56.62% | -17.05% | -70.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 95.75% | 654.05% | -72.82% | -63.36% | -63.80% |
|
|
|||||
| Total Current Assets | 95.75% | 654.05% | -72.82% | -63.36% | -63.80% |
| Net Property, Plant & Equipment | -43.90% | -39.56% | -35.35% | -32.41% | -29.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 10,833.33% | 0.00% |
| Total Assets | 48.24% | 256.13% | -40.38% | -40.20% | -47.67% |
|
|
|||||
| Total Accounts Payable | -73.10% | 61.06% | 81.09% | 516.91% | 460.95% |
| Total Accrued Expenses | 152.27% | 2,091.30% | 488.52% | 116.67% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.67% | 13.89% | 14.29% | 14.71% | 9.09% |
| Total Finance Division Other Current Liabilities | -- | 146.61% | -- | -- | -- |
| Total Other Current Liabilities | -- | 146.61% | -- | -- | -- |
| Total Current Liabilities | -74.53% | 107.85% | 128.22% | 597.27% | 507.66% |
|
|
|||||
| Total Current Liabilities | -74.53% | 107.85% | 128.22% | 597.27% | 507.66% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -86.27% | -69.49% | -57.97% | -48.72% | -41.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -74.63% | 104.19% | 121.24% | 532.26% | 461.15% |
|
|
|||||
| Common Stock & APIC | 34.83% | 36.53% | 16.58% | 10.50% | 3.58% |
| Retained Earnings | -22.74% | -25.64% | -25.69% | -26.94% | -23.22% |
| Treasury Stock & Other | 17.97% | -8.37% | -34.65% | -27.06% | -45.32% |
| Total Common Equity | 455.41% | 923.31% | -144.52% | -109.95% | -119.26% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 455.41% | 923.31% | -144.52% | -109.95% | -119.26% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 455.41% | 923.31% | -144.52% | -109.95% | -119.26% |
|
|
|||||